Change search
ReferencesLink to record
Permanent link

Direct link
Tc-99m-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis
Umea Univ, Dept Publ Hlth & Clin Med, Ctr Heart, Cardiol, SE-90185 Umea, Sweden..
Umea Univ, Dept Publ Hlth & Clin Med, SE-90185 Umea, Sweden..
Umea Univ, Dept Publ Hlth & Clin Med, Ctr Heart, Cardiol, SE-90185 Umea, Sweden..
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology. Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden..
Show others and affiliations
2016 (English)In: Upsala Journal of Medical Sciences, ISSN 0300-9734, E-ISSN 2000-1967, Vol. 121, no 1, 17-24 p.Article in journal (Refereed) PublishedText
Abstract [en]

Aims In transthyretin amyloid (ATTR) amyloidosis various principal phenotypes have been described: cardiac, neuropathic, or a mixed cardiac and neuropathic. In addition, two different types of amyloid fibrils have been identified (type A and type B). Type B fibrils have thus far only been found in predominantly early-onset V30M and in patients carrying the Y114C mutation, whereas type A is noted in all other mutations currently examined as well as in wild-type ATTR amyloidosis. The fibril type is a determinant of the ATTR V30M disease phenotype. Tc-99m-DPD scintigraphy is a highly sensitive method for diagnosing heart involvement in ATTR amyloidosis. The objective of this study was to determine the relationship between ATTR fibril composition and Tc-99m-DPD scintigraphy outcome in patients with biopsy-proven ATTR amyloidosis. Methods Altogether 55 patients with biopsy-proven diagnosis of ATTR amyloidosis and amyloid fibril composition determined were examined by Tc-99m-DPD scintigraphy. The patients were grouped and compared according to their type of amyloid fibrils. Cardiovascular evaluation included ECG, echocardiography, and cardiac biomarkers. The medical records were scrutinized to identify subjects with hypertension or other diseases that have an impact on cardiac dimensions. Results A total of 97% with type A and none of the patients with type B fibrils displayed Tc-99m-DPD uptake at scintigraphy (p < 0.001). Findings from analyses of cardiac biomarkers, ECG, and echocardiography, though significantly different, could not differentiate between type A and B fibrils in individual patients. Conclusion In ATTR amyloidosis, the outcome of Tc-99m-DPD scintigraphy is strongly related to the patients' transthyretin amyloid fibril composition.

Place, publisher, year, edition, pages
2016. Vol. 121, no 1, 17-24 p.
Keyword [en]
transthyretin, Amyloidosis hereditary, echocardiography, scintigraphy, amyloid cardiomyopathy
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-283799DOI: 10.3109/03009734.2015.1122687ISI: 000372123700003PubMedID: 26849806OAI: diva2:921273
Swedish Heart Lung Foundation
Available from: 2016-04-20 Created: 2016-04-14 Last updated: 2016-04-20Bibliographically approved

Open Access in DiVA

fulltext(1240 kB)53 downloads
File information
File name FULLTEXT01.pdfFile size 1240 kBChecksum SHA-512
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Westermark, Per
By organisation
Department of Immunology, Genetics and Pathology
In the same journal
Upsala Journal of Medical Sciences
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 53 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 332 hits
ReferencesLink to record
Permanent link

Direct link